Company: EUDAW
Filing Date: 2025-06-24
Form Type: 6-K
Source: 0001641172-25-016183
Chunk: 1

Company: EUDA Health Holdings Ltd
Filing Date: 2025-06-24
Form: 6-K
Chunk 1
---
 The Company will pay Chardan a commission equal to 3.0% of the gross sales proceeds of any Shares sold directly into the market, and 7.0% if sold through institutional or broker-to-broker “block” transactions under ATM Agreement.

The Company is not obligated to make any sales of the Shares under the ATM Agreement. The offering of the Shares will terminate upon the earlier of (i) the sale of all Shares subject to the ATM Agreement or (ii) termination of the ATM Agreement in accordance with its terms. The ATM Agreement contains customary representations, warrantees and agreements between the Company and Chardan, including customary indemnification rights, including for liabilities under the Securities Act. The representations, warranties and covenants contained in the ATM Agreement were made only for purposes of such agreement and as of specific dates and were solely for the benefit of the parties to such agreement.

The foregoing description of the ATM Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the ATM Agreement, a copy of which is filed as Exhibit 1.1 to this Current Report and incorporated by reference herein.

The legal opinion of Conyers Dill & Pearman Pte. Ltd. relating to the Shares being offered is filed herewith as Exhibit 5.1.

This Report on Form 6-K shall not constitute an offer to sell or the solicitation of an offer to buy the Ordinary Shares nor shall there be any sale of the Ordinary Shares in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

This Report on Form 6-K is incorporated by reference into the Company’s Registration Statement on Form F-3 (File No. 333-282723) and the prospectus thereof and any prospectus supplements or amendments thereto.

Exhibits

| 1.1  | At                                                                    
 the Market Offering Agreement dated June 23, 2025                     |
|:-----|:----------------------------------------------------------------------|
| 5.1  | Opinion of Conyers Dill & Pearman Pte. Ltd.                           |
| 23.1 | Consent of Conyers Dill & Pearman Pte. Ltd. (included in Exhibit 5.1) |

<div align='center'>SIGNATURE</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on